BeOne Medicines Ltd. (ONC)
NASDAQ: ONC
· Real-Time Price · USD
345.00
3.20 (0.94%)
At close: Sep 08, 2025, 1:28 PM
BeOne Medicines Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|
| Product Revenue | 1.66B | 1.4B |
| Product Revenue Growth | +18.41% | n/a |
| Collaboration Revenue | 13.22M | 8.75M |
| Collaboration Revenue Growth | +51.15% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|
| All Other Countries Except China And United States Of America Revenue | 35.56M | 31.92M |
| All Other Countries Except China And United States Of America Revenue Growth | +11.41% | n/a |
| China Revenue | 432.92M | 399.59M |
| China Revenue Growth | +8.34% | n/a |
| Europe Revenue | 152.38M | 118.55M |
| Europe Revenue Growth | +28.54% | n/a |
| United States Revenue | 694.43M | 567.21M |
| United States Revenue Growth | +22.43% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 537.91M | 459.27M | 504.68M | 455.22M | 443.73M | 427.43M | 416.55M | 364.42M | 395.03M | 328.5M | 328.98M | 322.89M | 331.4M | 294.57M | 306.5M | 269.23M | 232.29M | 182.11M | 208.21M | 160.84M | 124.05M | 107.08M | 143.35M | 105M | 82.25M | 57.65M | 72.49M | 48.82M | 45.16M | 28.91M | 27.41M | 15.64M | 10.78M | 8.77M | 8.34M | 4.72M | 3.9M | 3.13M | 2.95M | 2.02M | 1.21M | 1.13M |
| Selling, General, and Administrative Revenue Growth | +17.12% | -9.00% | +10.86% | +2.59% | +3.81% | +2.61% | +14.30% | -7.75% | +20.25% | -0.15% | +1.89% | -2.57% | +12.50% | -3.89% | +13.84% | +15.90% | +27.56% | -12.54% | +29.45% | +29.66% | +15.85% | -25.30% | +36.53% | +27.67% | +42.68% | -20.48% | +48.48% | +8.10% | +56.18% | +5.47% | +75.28% | +45.13% | +22.90% | +5.18% | +76.56% | +20.95% | +24.57% | +6.24% | +45.97% | +67.30% | +6.71% | n/a |
| Research and Development Revenue | 524.9M | 481.89M | 542.01M | 496.18M | 454.47M | 460.64M | 493.99M | 453.26M | 422.76M | 408.58M | 446.02M | 426.36M | 378.21M | 389.92M | 430.49M | 351.94M | 356.09M | 320.73M | 355.54M | 349.07M | 285.97M | 304.3M | 283.26M | 236.97M | 228.76M | 178.35M | 257.46M | 147.59M | 164.25M | 109.7M | 91.34M | 87.66M | 47.24M | 42.77M | 28.93M | 30.11M | 21.12M | 17.88M | 28.1M | 13.35M | 6.74M | 10.06M |
| Research and Development Revenue Growth | +8.93% | -11.09% | +9.24% | +9.18% | -1.34% | -6.75% | +8.99% | +7.21% | +3.47% | -8.39% | +4.61% | +12.73% | -3.00% | -9.42% | +22.32% | -1.17% | +11.03% | -9.79% | +1.85% | +22.07% | -6.02% | +7.43% | +19.53% | +3.59% | +28.26% | -30.73% | +74.45% | -10.14% | +49.73% | +20.10% | +4.20% | +85.54% | +10.46% | +47.83% | -3.90% | +42.57% | +18.12% | -36.39% | +110.49% | +98.17% | -33.03% | n/a |